Juvenile Diabetes Research Foundation Canada
Toronto, ON M2J 5A9
President & CEO: Dave Prowten
Board Chair: Matt Varey
Website: www.jdrf.ca
Charitable Reg. #: 11897 6604 RR0001
Charity Rating
Donor Accountability
Grade: B
The grade is based on the charity's public reporting of the work it does and the results it achieves.Financial Transparency
Need for Funding
Spending Breakdown
Full-time staff #105
Avg. Compensation $69,865
Top 10 Staff Salary Range
| $350k + | 0 |
| $300k - $350k | 0 |
| $250k - $300k | 0 |
| $200k - $250k | 1 |
| $160k - $200k | 0 |
| $120k - $160k | 3 |
| $80k - $120k | 6 |
| $40k - $80k | 0 |
| < $40k | 0 |
About Juvenile Diabetes Research Foundation Canada:
Founded in 1974 by parents of children with diabetes, Juvenile Diabetes Research Foundation Canada (JDRF) is the largest funder and advocate for Type 1 diabetes (T1D) research. Its focus is to find a cure for T1D and its complications. JDRF reports that 300,000 Canadians live with T1D. On average, T1D management requires 1,460 insulin shots a year. T1D often leads to life-threatening and debilitating complications which may include kidney failure, blindness, heart disease, stroke, nerve damage and amputation. The frequency of T1D among children under the age of 14 is rising, with rates doubling over the last 20 years in children under 5 years old. JDRF funds research focused on three main ideas: cure, prevention and treatment. Its main research focus includes immune therapies, regeneration, replacement, prevention, artificial pancreas, glucose control therapy and complications prevention.
In F2015, Juvenile Diabetes Research Foundation Canada awarded 121 new research grants, funding 200 global institutions and 39 research projects in Canada. The grants also funded 50 active clinical trials globally. In F2015, 350 principal investigators received funding from JDRF.
JDRF’s research surrounding an artificial pancreas is a revolutionary advance in diabetes care. In F2014, the artificial pancreas received USFDA approval. JDRF's research milestones also include beta cell encapsulation (implanting stem cells to "heal" T1D). In F2015, the first cohort of Canadian participants began testing the safety of the encapsulation product. In F2016, JDRF plans to test the tolerability and efficacy of the product, which could allow those with T1D to live free of insulin injections. Finally, JDRF’s stem cell research focuses on converting stem cells into insulin-producing pancreatic cells. This can rapidly reverse diabetes following a transplant.
Financial Review:
Juvenile Diabetes Research Foundation Canada is a Major 100 charity, with donations of $20m in F2015. Its fundraising costs are 49% of donations and its administrative costs are 21% of revenues. JDRF spends more on fundraising than it does on T1D programs and research due to high-cost fundraising events. For every $1 donated to the charity, 30 cents is put towards its programs, falling well below Ci’s reasonable range. The charity’s funding reserves of $8.5m include $86k in donor-endowed funds. This results in a program cost coverage ratio, excluding donor-endowed funds, of 94%. This means that the charity can cover 11 months of its annual programs using its existing reserves.
This charity report is an update that is being reviewed by Juvenile Diabetes Research Foundation Canada. Changes and edits may be forthcoming.
Updated on August 2, 2016 by Lynn Tay.
Financial RatiosFiscal year ending December |
2015 | 2014 | 2013 |
|---|---|---|---|
| Administrative costs as % of revenues | 20.9% | 18.7% | 14.4% |
| Fundraising costs as % of donations | 48.8% | 47.1% | 52.4% |
| Program cost coverage (%) | 94.7% | 105.7% | 184.1% |
Summary Financial StatementsAll figures in $000s |
2015 | 2014 | 2013 |
|---|---|---|---|
| Donations | 20,005 | 20,908 | 23,064 |
| Lotteries (net) | 272 | 427 | 428 |
| Investment income | 128 | 235 | 30 |
| Total revenues | 20,405 | 21,570 | 23,522 |
| Program costs | 1,118 | 1,184 | 1,128 |
| Grants | 7,862 | 8,710 | 5,780 |
| Administrative costs | 4,233 | 3,997 | 3,371 |
| Fundraising costs | 9,757 | 9,839 | 12,096 |
| Cash flow from operations | (2,565) | (2,160) | 1,147 |
| Funding reserves | 8,501 | 10,455 | 12,719 |
For more information on Canadian charities, please visit www.charityintelligence.ca
The information in this report was prepared by Charity Intelligence Canada and its independent analysts from publically-available information. Charity Intelligence Canada and its analysts have made endeavours to ensure that the data in this report is accurate and complete but accept no liability. No attempt has been made to examine the effectiveness of the charities' programs.
Comments added by the Charity:
These comments refer to a previous Charity Intelligence profile:
JDRF directs funds to deliver both near-term benefits for people who live with type 1 diabetes and, ultimately, a cure. Our research focus is on two distinct and related aims of science leading to a cure and science leading to better treatments. JDRF also provides outreach support services, volunteer and advocacy opportunities.
Canada’s excellence in diabetes research and breakthroughs continues in the creation of the JDRF Canadian Clinical Trial Network. Launched in 2010 through a partnership with the Government of Canada, JDRF CCTN began as a $33.9M investment to accelerate the testing of new technologies and treatments for Canadians living with type 1 diabetes and its complications.
JDRF is positively impacting the lives and futures of people living with diabetes. Thanks to the support of our generous donors, JDRF has made significant advancements and progress toward positive health outcomes for people living with type 1 diabetes. For example:
We remain committed to a cure while investing in better treatments for today.